findmyKOL
Clinical trialNCT05436652CompletedPhase 2Interventional

A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)

SponsorSparrow PharmaceuticalsEnrollment66Polymyalgia Rheumatica
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Universitätsmedizin Berlin, Medizinische Klinik Mit Schwerpunkt Rheumatologie Und Klinische Immunologie

    Berlin, Germany

  • Internistische Praxisgemeinschaft Rheumatologie Nephrologie

    Erlangen, Germany

  • Hamburger Rheuma Forschungszentrum Ii Im Mvz Für Rheumatologie Und Autoimmunmedizin

    Hamburg, Germany

  • Katholische Kliniken Rhein-Ruhr Am Marien Hospital, Universitätsklinik Der Ruhr-Universität

    Herne, Germany

  • Universitätsmedizin Der Johannes Gutenberg Universität Mainz

    Mainz, Germany

  • Praxis Prof. Dr. Med. Herbert Kellner

    Munich, Germany

Poland
  • Novareuma

    Bialystok, Poland

  • the University of Gdańsk

    Gdansk, Poland

  • Mics Centrum Medyczne Warszawa

    Warsaw, Poland

  • Dolnośląski Szpital Specjalistyczny Im. T. Marciniaka

    Wroclaw, Poland

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Jul 2022
Primary completion
25 Apr 2025
Completion
25 Apr 2025
Last update posted
11 May 2025
Registered enrollment
66
Registry id
NCT05436652

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.